The Occurrence of Subsequent Malignancy in Patients Presenting with Deep Vein Thrombosis: Results from a Historical Cohort Study

Raghu Rajan; Mark Levine; Michael Gent; Jack Hirsh; William Geerts; Peter Skingley; Jim Julian

doi:10.1055/s-0037-1614211

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1998; 79(01): 19-22
DOI: 10.1055/s-0037-1614211

Review Article

Schattauer GmbH

The Occurrence of Subsequent Malignancy in Patients Presenting with Deep Vein Thrombosis: Results from a Historical Cohort Study

Autor*innen

Raghu Rajan

¹From the Departments of Medicine and Clinical Epidemiology & Biostatistics, McMaster University, Hamilton Civic Hospitals Research Centre, Hamilton, Ontario, and University of Toronto, Toronto, Ontario, Canada
Mark Levine

¹From the Departments of Medicine and Clinical Epidemiology & Biostatistics, McMaster University, Hamilton Civic Hospitals Research Centre, Hamilton, Ontario, and University of Toronto, Toronto, Ontario, Canada
Michael Gent

¹From the Departments of Medicine and Clinical Epidemiology & Biostatistics, McMaster University, Hamilton Civic Hospitals Research Centre, Hamilton, Ontario, and University of Toronto, Toronto, Ontario, Canada
Jack Hirsh

¹From the Departments of Medicine and Clinical Epidemiology & Biostatistics, McMaster University, Hamilton Civic Hospitals Research Centre, Hamilton, Ontario, and University of Toronto, Toronto, Ontario, Canada
William Geerts

¹From the Departments of Medicine and Clinical Epidemiology & Biostatistics, McMaster University, Hamilton Civic Hospitals Research Centre, Hamilton, Ontario, and University of Toronto, Toronto, Ontario, Canada
Peter Skingley

¹From the Departments of Medicine and Clinical Epidemiology & Biostatistics, McMaster University, Hamilton Civic Hospitals Research Centre, Hamilton, Ontario, and University of Toronto, Toronto, Ontario, Canada
Jim Julian

¹From the Departments of Medicine and Clinical Epidemiology & Biostatistics, McMaster University, Hamilton Civic Hospitals Research Centre, Hamilton, Ontario, and University of Toronto, Toronto, Ontario, Canada

Abstract

Summary

Background: Several studies have reported that patients who present with idiopathic deep vein thrombosis (DVT) have an increased risk of subsequently developing cancer. A clinical trial had previously been conducted examining the optimal duration of oral anticoagulant therapy following initial heparin treatment in patients with proximal DVT.

Methods: A historical cohort study was performed on patients enrolled in the duration of anticoagulant trial. Patients known to have cancer at the time of entry into the trial were excluded. The qualifying DVTs were classified as idiopathic (no known associated risk factors) or secondary without knowledge of subsequent recurrent venous thrombosis or cancer. The patients were then followed for the development of cancer.

Results: Thirteen (8.6%) of the 152 patients in the idiopathic cohort subsequently developed cancer compared to eight (7.1%) of 112 patients in the secondary cohort, P = 0.86. Two (5.4%) of 37 patients with recurrent venous thromboembolism and 19 (8.4%) of 227 patients without recurrent thromboembolism developed cancer, P = 0.7.

Conclusion: Our study did not detect an increased risk of subsequent cancer in patients presenting with idiopathic DVT compared to secondary DVT; nor did we detect an increased incidence of cancer in patients with recurrent venous thromboembolism. Further studies are required prior to pursuing a policy of aggressive screening for cancer in patients with idiopathic venous thromboembolism.

Volltext

Referenzen

References
1 Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients.. Ca Med Rev 1992; 11: 237-48.
2 Goldberg RJ, Seneff M, Gore JM. et al. Occult malignant neoplasm in patients with deep vein thrombosis.. Arch Intern Med 1987; 147: 251-3.
3 Griffin MR, Stanson AW, Brown ML. et al. Deep venous thrombosis and pulmonary embolism: risk of subsequent malignant neoplasm.. Arch Intern Med 1987; 147: 1907-11.
4 Cornuz J, Pearson SD, Creager Ma, Cook EF, Goldman L. Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis.. Ann Inter Med 1996; 125: 785-93.
5 Monreal M, Lafoz E, Casals A. et al. Occult cancer in patients with venous thrombosis: a systematic approach.. Cancer 1991; 67: 541-5.
6 Aderka D, Brown A, Zelikovski A, Pinkas J. Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sign of occult cancer.. Cancer 1986; 57: 1846-9.
7 Prandoni P, Lensing AW, Büller HR. et al. Deep vein thrombosis and the incidence of subsequent symptomatic cancer.. N Engl J Med 1992; 327: 1128-33.
8 Nordstrom M, Linblad B, Anderson H, Bergqvist D, Kjellstrom T. Deep vein thrombosis and occult malignancy: an epidemiological study.. BMJ 1994; 308: 891-4.
9 Levine MN, Hirsh J, Gent M. et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.. Thromb Haemost 1995; 74: 606-11.
10 Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.. J Am Stat Assoc 1958; 53: 457-81.
11 Cox DR. Regression models and life tables.. J Royal Stat Soc B 1972; 34: 187-220.
12 Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Early diagnosis. In: Clinical Epidemiology A Basic Science for Clinical Medicine.. Little, Brown; Boston: pp 153-70.